)

Kuros Biosciences (KURN) investor relations material
Kuros Biosciences H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved 78% year-over-year revenue growth in H1 2025, reaching USD 63.5 million, with first-ever operating profit of USD 3.5 million and strong momentum in MagnetOs sales and international expansion.
Strong commercial execution in spine and extremities segments, supported by the Medtronic partnership, new product launches like the MIS applicator, and significant U.S. and international market share gains.
Expanded U.S. presence with new headquarters and production facility, and advanced global reach through regulatory approvals in Brazil, Lebanon, and ongoing registrations in multiple countries.
Hosted inaugural Capital Markets Day, strengthened brand recognition, and increased sales agent and hospital penetration.
Discontinued Pharmaceuticals segment, integrating legacy activities into the Legacy Portfolio.
Financial highlights
H1 2025 revenue reached USD 63.5 million, up from USD 35.7 million in H1 2024, with gross profit of USD 56.3 million and gross margin exceeding 88%.
Achieved first-time operating profit (EBIT) of USD 3.5 million and adjusted EBITDA of USD 7.8 million (margin 11.6–12.9%).
Robust cash and funds available for operations totaled USD 18.4–45.3 million as of June 30, 2025.
Cash flow now sufficient to fund organic growth, CapEx, and working capital internally.
Net loss for the period was USD 2.0 million, mainly due to higher finance expenses.
Outlook and guidance
Targeting at least 60% sales growth in 2025, with H2 expected to follow historical phasing and sales projected at USD 220–250 million by 2027.
Margin improvement expected to continue gradually, with ongoing investments in digitization, automation, and innovation.
New U.S. production facility in Atlanta scheduled to open in H2 2026, supporting further expansion.
Anticipates full commercial launch of MagnetOs MIS system in the U.S. in fall 2025.
Ongoing supply chain redesign to optimize tariffs, taxes, and de-risk operations.
Next Kuros Biosciences earnings date

Next Kuros Biosciences earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage